Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN)

Today during trading, Nervgen Pharma Corp stock opened at $2.33 and closed at $2.43. prices ranged from $2.26 to $2.44.

The price raised 3.40 percent from the previous day's close of $2.35.

Today across North America, the TSX Composite closed 0.34% at 21961.55, the S&P 500 closed 0.27% at 5375.32, the Dow Jones Industrial Average closed -0.31% at 38747.42 and the Nasdaq Composite closed 0.88% at 17343.55.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 245,109 shares was traded during the session, with total trades of 255, with an average volume of 205,068 in the last five days.

Trading across the entire TSX-V saw 3,171 price advancers against 1,986 declines and 97 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have jumped 41.28 percent, while this year, they have eased -10.00%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $164.33 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..